Getting to know the chief pharmaceutical officer's clinical fellows Justin, Tahmina and Khola

| March 22, 2018

article image
I am currently based at Bupa and work alongside two fellows from the National Medical Director’s Clinical Fellow Scheme. Prior to the scheme I gained experience in various pharmacy specialities within secondary care. I am primarily a surgical specialist pharmacist although I have undertaken roles in clinical governance, critical care and most recently as an independent prescriber in pain. I also have a keen interest in education and currently also work for Robert Gordon University as part of their pharmacy postgraduate courses. My days are focused on one of several agreed work streams including clinical governance, the EU Falsified Medicines Directive and digital health applications. Within these work streams my level of responsibility varies from providing support as a technical expert to both leading and managing the project. There are also many opportunities which have arisen to undertake specialist training such as strategy or project management.

Spotlight

Denis Chem Lab Ltd

We are a Public Limited Pharmaceutical Company incorporated in 1982. We started commercial production for sterile Intravenous injectibles in 1984. Since more than 30 years we have been actively delivering high quality sterile Intravenous injectibles and contributing in saving lives. We Manufacture and market sterile Intravenous injectibles in Both Glass and Plastic Bottles with capacity of 810 million bottles per Annum.

OTHER ARTICLES

Clinical Supply Availability & Speed to Study Start-Up

Article | March 26, 2020

If you’re part of a clinical study team racing a new product to commercialization, you likely live by these two simple rules: time is money, and the first one to market wins. But just because it’s simple doesn’t mean it’s easy. That ticking clock is background noise to the responsibilities of regulations, study protocols, supply chains, and patient recruitment — all the details that must be worked out before a study can even begin. The pressure is always there. The longer it takes for a study to start, the longer it takes to complete.

Read More

Merck’s Patient-Centric Clinical Trial Recruiting

Article | March 26, 2020

Everyone in pharma knows that product success depends on the results of clinical trials — but we don’t usually hear from the people who are involved in running them. Recently, four Clinical Research Managers (CRM) from Merck (known as MSD outside the United States and Canada) discussed how Merck is overcoming the barriers to clinical trial recruitment by adopting a patient-centric process — a model that affects their trials top to bottom, from design through implementation. Each of the panel members manages clinical trials, serving as the main point of interaction with the Clinical Research Associates (CRAs) on research requirements, goals, and resources, including recruiting and retention.

Read More

How Can Medical Cannabis Help to Manage Pain Conditions? – The Cannabis Exchange

Article | March 26, 2020

Pain management is one of the most common reasons for the use of medical cannabis products. However, despite many jurisdictions – including Canada, Germany, and the Netherlands – now allowing the prescription of medical cannabis for this purpose, there remains little ‘high-quality’ evidence to support, or oppose its efficacy. Madden et al. (2018) set out to review the evidence available in order to determine the efficacy of medical cannabis when employed in the management of various forms of musculoskeletal pain. The researchers analysed various studies that assessed the use of cannabinoids in the treatment of arthritis pain; back pain; postoperative pain; and trauma-related pain. It is estimated that up to 30% of the population may suffer from a non-cancer-related pain condition. As such a high percentage of people suffer from these conditions, the development of simple and safe therapies is an essential area of research. This is particularly important as the therapeutic options for people with chronic pain are increasingly limited.

Read More

Enabling Active Pharma Ingredients for Batch Balancing and Integration to SAP EWM

Article | March 26, 2020

Batch and its Classification system are two most potent weapons used in Chemical, Pharma or Medical life science industry to record the potency of a batch or technically called as Active Pharma Ingredients(API). These material consist of one or more active ingredients, concentrates, carrier materials, or impurities, and so on. The potency of the active ingredients varies from batch to batch. The active ingredient is the substance of greatest interest in the bill of materials, the proportion of which may vary from batch to batch. Therefore, during creation of a process order, the system must be able to select and adjust the batches needed to obtain the required amount of active ingredient. Take an example of a drug hydroxychloroquine which is used as potent weapon to fight COVID-19. This drug is manufactured by using API, however, the Potency of this API material vary from batch to batch. To map this kind of requirement in SAP ERP, SAP calls it as Material Quantity Calculation.

Read More

Spotlight

Denis Chem Lab Ltd

We are a Public Limited Pharmaceutical Company incorporated in 1982. We started commercial production for sterile Intravenous injectibles in 1984. Since more than 30 years we have been actively delivering high quality sterile Intravenous injectibles and contributing in saving lives. We Manufacture and market sterile Intravenous injectibles in Both Glass and Plastic Bottles with capacity of 810 million bottles per Annum.

Events